tiprankstipranks
Trending News
More News >
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market
Advertisement

Altamira Therapeutics (CYTOF) Technical Analysis

Compare
599 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Altamira Therapeutics’s (CYTOF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Altamira Therapeutics is a Sell.
Altamira Therapeutics’s (CYTOF) 20-Day exponential moving average is 0.07, while Altamira Therapeutics’s (CYTOF) share price is <$0.1, making it a Buy.
Altamira Therapeutics’s (CYTOF) 50-Day exponential moving average is 0.07, while Altamira Therapeutics’s (CYTOF) share price is <$0.1, making it a Buy.

Altamira Therapeutics (CYTOF) Pivot Points

Oct 03, 2025, 07:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Fibonacci
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Altamira Therapeutics (CYTOF) Moving Averages

Oct 03, 2025, 07:21 AM
Period
Simple
Exponential
MA5
0.07Buy
0.08Buy
MA10
0.07Buy
0.07Buy
MA20
0.06Buy
0.07Buy
MA50
0.07Buy
0.07Buy
MA100
0.08Buy
0.09Buy
MA200
0.10Buy
0.15Sell
Altamira Therapeutics’s (CYTOF) 10-Day exponential moving average is 0.07, while Altamira Therapeutics’s (CYTOF) share price is <$0.1, making it a Buy.
Altamira Therapeutics’s (CYTOF) 100-Day exponential moving average is 0.09, while Altamira Therapeutics’s (CYTOF) share price is <$0.1, making it a Buy.
Altamira Therapeutics’s (CYTOF) stock price is <$0.1 and Altamira Therapeutics’s (CYTOF) 50-day simple moving average is 0.07, creating a Buy signal.
Altamira Therapeutics’s (CYTOF) stock price is <$0.1 and Altamira Therapeutics’s (CYTOF) 100-day simple moving average is 0.08, creating a Buy signal.
Altamira Therapeutics’s (CYTOF) stock price is <$0.1 and Altamira Therapeutics’s (CYTOF) 200-day simple moving average is 0.10, creating a Buy signal.

Altamira Therapeutics (CYTOF) Technical Indicators

Oct 03, 2025, 07:21 AM
Name
Value
Implied Action
RSI (14)
62.65
Neutral
STOCH (9,6)
30.55
Neutral
STOCHRSI (14)
36.04
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
56.98
Sell
Williams %R
-18.92
Sell
CCI (14)
191.75
Sell
ATR (14)
0.02
-
Ultimate Oscillator
32.67
Neutral
ROC
22.22
Buy
Altamira Therapeutics’s (CYTOF) Relative Strength Index (RSI) is 62.65, creating a Neutral signal.
Altamira Therapeutics’s (CYTOF) Trend Strength Indicator (ADX) is 56.98, creating a Sell signal.
Altamira Therapeutics’s (CYTOF) Commodity Channel Index (CCI) is 191.75, creating a Sell signal.
Altamira Therapeutics’s (CYTOF) Price Rate of Change (ROC) is 22.22, creating a Buy signal.

FAQ

Is CYTOF a Buy, Hold, or Sell?
Based on CYTOF’s technical indicators, CYTOF is a Buy.
    What is CYTOF’s RSI (14)?
    CYTOF’s RSI (14) is 62.65, which suggests CYTOF is a Neutral.
      What is CYTOF’s MACD?
      CYTOF’s MACD is <0.01, which suggests CYTOF is a Sell.
        What is CYTOF’s 5-day moving average?
        CYTOF’s 5-day moving average is 0.07, which suggests CYTOF is a Buy.
          What is CYTOF’s 20-day moving average?
          CYTOF 20-day moving average is 0.06, which suggests CYTOF is a Buy.
            What is CYTOF’s 50-day moving average?
            CYTOF’s 50-day moving average is 0.07, which suggests CYTOF is a Buy.
              What is CYTOF’s 200-day moving average?
              CYTOF’s 200-day moving average is 0.10, which suggests CYTOF is a Buy.
                What is CYTOF’s Williams % R (14)?
                CYTOF’s Williams % R (14) is -18.92, which suggests CYTOF is a Sell.
                  What is CYTOF’s CCI (14)?
                  CYTOF’s CCI (14) is 191.75, which suggests CYTOF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis